Ginseng in Prevention and Treatment of Diabetes PI: Kenneth S. Polonsky MD, Busch Professor of Medicine and Chairman of the Department of Medicine, Washington University School of Medicine Funding period: 10/1/04 – 9/30/05 Abstract
Subjects with impaired glucose tolerance (IGT) are at particularly high risk for diabetes;
over time, 50% or more will develop overt diabetes. Ginseng root is one of the most commonly used natural remedies in the United States and has been purported to improve glucose tolerance and prevent diabetes. Ginsenoside Re, a major constituent, has been implicated in the anti- diabetic effects of ginseng. The already widespread use of ginseng by the general population make it a potentially appealing agent for the prevention and/or treatment of type 2 diabetes, if safety and efficacy could be demonstrated in carefully cont rolled clinical studies. The present proposal details plans to study the metabolic effects of ginseng and ginsenoside Re in subjects with impaired glucose tolerance. The specific aims are: 1. To determine the effect of ginseng extract and ginsenoside Re on: a) glucose tolerance, b) basal glucose production, glucose disposal and lipolytic rate, and c) insulin action in adipose tissue, liver, and skeletal muscle. The hypothesis will be tested that ginseng extract and ginsenoside Re will improve glucose tolerance in subjects with IGT by decreasing basal glucose production and lipolytic rates and enhancing insulin-mediated suppression of glucose Ra and glycerol Ra, and stimulation of glucose Rd. 2. To determine the effect of ginseng extract and ginsenoside Re on pancreatic beta-cell function. The hypothesis will be tested that ginseng extract and ginsenoside Re will improve pancreatic beta cell sensitivity to glucose in subjects with IGT. 3. To determine the effect of ginseng extract and ginsenoside RE on skeletal muscle insulin signaling. The results from this study could lead to the development of a new and important approach to the prevention and/or treatment of type 2 diabetes, if the hypotheses posed above prove to be correct and if ginseng and/or ginsenoside Re are well tolerated. Lay Summary Impaired glucose tolerance is a condition associated with increases in plasma glucose concentrations not severe enough to be classed as diabetic. However, over time a very high proportion of subjects do progress to diabetes. In the present study, we will determine whether ginseng root, a widely used natural remedy and ginsenoside Re, one of the active components of ginseng, can improve glucose tolerance and enhance insulin secretion or insulin action. If ginseng or ginsenoside Re could be demonstrated to possess these therapeutic actions, it would become a very appealing agent that could be used worldwide to reduce the burden of diabetes.
Director-General's Statement Under Section 98 of the Medicines A. http://www.moh.govt.nz/moh.nsf/0/3711B8F68E771F8FCC257. Media Release 1 March 2006 Director-General's Statement Under Section 98 of the Medicines Act 1981 Director-General of Health Dr Karen Poutasi is today warning people against taking two herbal products after testing revealed they contained undeclared prescripti
Onium Chemicals B.V., The Netherlands T.: +31(0)6 20171394; F.: +31(0)847233093; Mail : [email protected] Productlist API based on product in alphabetical For products detailed specifications or MSDS, please contact us by email to [email protected] PRODUCT NAME APPLICATION 7689-03-4 (+)-Camptothecin 200815-49-2 (R,R)-Formoterol-L-(+)-Tartrate 826